vimarsana.com
Home
Live Updates
OKYO Pharma Limited Receives Nasdaq Deficiency Notice : comparemela.com
OKYO Pharma Limited Receives Nasdaq Deficiency Notice
NEW YORK, July 28, 2023 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (Nasdaq: OKYO) ("OKYO" or the "Company"), an ophthalmology-focused bio-pharmaceutical...
Related Keywords
Garys Jacob ,
Paul Spencer ,
Nasdaq ,
Pharma Limited Nasdaq ,
Nasdaq Listing Qualifications Panel The ,
Listing Qualifications Department ,
Nasdaq Stock Market ,
Nasdaq Capital Market ,
Nasdaq Listing Rule ,
Nasdaq Capital ,
Market Value ,
Compliance Date ,
Compliance Period Rule ,
Market Value Rule ,
Nasdaq Listing Qualifications Panel ,
Chief Executive ,
Nasdaq Okyo ,
Okyo Pharma Ltd ,
comparemela.com © 2020. All Rights Reserved.